Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Both man and woman who is over 19 years old~* Patient with dyslipidemia and hypertension~Exclusion Criteria:~* sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg~* A history of cardiovascular disease~* Rhabdomyolysis, myopathy~* Hypertension or hypercholesterolemia due to secondary causes~* Uncontrolled diabetes~* Evidence of hepatic or renal disease

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- YHP1701 (Type: EXPERIMENTAL): PO, Once daily (QD), 8 weeks
- YHR1703 (Type: ACTIVE_COMPARATOR): PO, Once daily (QD), 8 weeks
- YHR1704 (Type: ACTIVE_COMPARATOR): PO, Once daily (QD), 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).